Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An expanding range of targets for kynurenine metabolites of tryptophan
Trevor W. Stone, Nicholas Stoy, L. Gail Darlington
Trends in Pharmacological Sciences (2012) Vol. 34, Iss. 2, pp. 136-143
Open Access | Times Cited: 312

Showing 1-25 of 312 citing articles:

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten, Ellen A. A. Nollen, Ute F. Röhrig, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 5, pp. 379-401
Open Access | Times Cited: 1113
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
Igor Červenka, Leandro Z. Agudelo, Jorge L. Ruas
Science (2017) Vol. 357, Iss. 6349
Closed Access | Times Cited: 1020
Minireview: Gut Microbiota: The Neglected Endocrine Organ
Gerard Clarke, Roman M. Stilling, Paul J. Kennedy, et al.
Molecular Endocrinology (2014) Vol. 28, Iss. 8, pp. 1221-1238
Open Access | Times Cited: 1019
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Iain A. Murray, Andrew D. Patterson, Gary H. Perdew
Nature reviews. Cancer (2014) Vol. 14, Iss. 12, pp. 801-814
Open Access | Times Cited: 769
Aryl hydrocarbon receptor control of a disease tolerance defence pathway
Alban Bessede, Marco Gargaro, Maria Teresa Pallotta, et al.
Nature (2014) Vol. 511, Iss. 7508, pp. 184-190
Open Access | Times Cited: 616
Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis
Susan Westfall, Nikita Lomis, Imen Kahouli, et al.
Cellular and Molecular Life Sciences (2017) Vol. 74, Iss. 20, pp. 3769-3787
Open Access | Times Cited: 452
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression
Ahmed Sadik, Luis F. Somarribas Patterson, Selcen Öztürk, et al.
Cell (2020) Vol. 182, Iss. 5, pp. 1252-1270.e34
Open Access | Times Cited: 374
The kynurenine pathway and the brain: Challenges, controversies and promises
Robert Schwarcz, Trevor W. Stone
Neuropharmacology (2016) Vol. 112, pp. 237-247
Open Access | Times Cited: 354
Irritable bowel syndrome: A microbiome-gut-brain axis disorder?
Paul J. Kennedy
World Journal of Gastroenterology (2014) Vol. 20, Iss. 39, pp. 14105-14105
Open Access | Times Cited: 297
The Impact of Microbiota on Brain and Behavior: Mechanisms & Therapeutic Potential
Yuliya Borre, Rachel D. Moloney, Gerard Clarke, et al.
Advances in experimental medicine and biology (2014), pp. 373-403
Closed Access | Times Cited: 296
Tryptophan Biochemistry: Structural, Nutritional, Metabolic, and Medical Aspects in Humans
Lionella Palego, Laura Betti, Alessandra Rossi, et al.
Journal of Amino Acids (2016) Vol. 2016, pp. 1-13
Open Access | Times Cited: 286
A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality
Cecilie Bay-Richter, Klas R. Linderholm, Chai K. Lim, et al.
Brain Behavior and Immunity (2014) Vol. 43, pp. 110-117
Closed Access | Times Cited: 276
A review of the relationship between the gut microbiota and amino acid metabolism
Rui Lin, Wentian Liu, Meiyu Piao, et al.
Amino Acids (2017) Vol. 49, Iss. 12, pp. 2083-2090
Closed Access | Times Cited: 265
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Kai Tang, Yahong Wu, Yihui Song, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 253
The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease
Gerwyn Morris, Michael Berk, André F. Carvalho, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 6, pp. 4432-4451
Closed Access | Times Cited: 248
Obesity and Cancer: Existing and New Hypotheses for a Causal Connection
Trevor W. Stone, Megan McPherson, L. Gail Darlington
EBioMedicine (2018) Vol. 30, pp. 14-28
Open Access | Times Cited: 244
Applications for α-lactalbumin in human nutrition
Donald K. Layman, Bo Lönnerdal, John D. Fernstrom
Nutrition Reviews (2018) Vol. 76, Iss. 6, pp. 444-460
Open Access | Times Cited: 238
The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders
Trevor W. Stone, L. Gail Darlington
British Journal of Pharmacology (2013) Vol. 169, Iss. 6, pp. 1211-1227
Open Access | Times Cited: 235
Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation
Leandro Z. Agudelo, Duarte M. S. Ferreira, Igor Červenka, et al.
Cell Metabolism (2018) Vol. 27, Iss. 2, pp. 378-392.e5
Open Access | Times Cited: 232
Amino acid auxotrophy as a system of immunological control nodes
Peter J. Murray
Nature Immunology (2016) Vol. 17, Iss. 2, pp. 132-139
Open Access | Times Cited: 227
Constitutive aryl hydrocarbon receptor signaling constrains type I interferon–mediated antiviral innate defense
Taisho Yamada, Hiromasa Horimoto, Takeshi Kameyama, et al.
Nature Immunology (2016) Vol. 17, Iss. 6, pp. 687-694
Open Access | Times Cited: 219
Is the HPA Axis as Target for Depression Outdated, or Is There a New Hope?
Andreas Menke
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 215
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
Eric Plitman, Yusuke Iwata, Fernando Caravaggio, et al.
Schizophrenia Bulletin (2017) Vol. 43, Iss. 4, pp. 764-777
Open Access | Times Cited: 196
Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
Ute F. Röhrig, Somi Reddy Majjigapu, Pierre Vogel, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 24, pp. 9421-9437
Open Access | Times Cited: 191
IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
Yi-Shu Huang, Joy Ogbechi, Felix I. L. Clanchy, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 147
Page 1 - Next Page

Scroll to top